Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Mankind Pharma Ltd Financial Statements & Historical Data

Updated NSE: MANKINDBSE: 543904
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 8 October 2026, 5:43 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,380₹ per share
Reported P/E43.6Times
Book value per share397₹ per share
Reported ROCE13.7 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 8 October 2026, 5:43 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap98,508 Cr.
Current Price2,380
High / Low2,642/1,910
Stock P/E43.6
Book Value397
Dividend Yield0.04 %
ROCE13.7 %
ROE13.8 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Mankind Pharma Ltd 98,508 Cr. 2,380 2,642/1,91043.6 3970.04 %13.7 %13.8 % 1.00
Dr Reddys Laboratories Ltd 99,911 Cr. 1,197 1,415/1,08031.0 4540.67 %13.0 %11.2 % 1.00
Aurobindo Pharma Ltd 94,309 Cr. 1,642 1,740/1,07524.9 6520.24 %12.9 %10.1 % 1.00
Cipla Ltd 1,05,249 Cr. 1,301 1,673/1,16629.4 4261.00 %15.5 %11.6 % 2.00
Lupin Ltd 89,234 Cr. 1,956 2,530/1,90015.0 4910.92 %29.9 %28.7 % 2.00
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Mankind Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 2,0922,2602,2092,0072,4132,5442,4142,1192,5702,6092,6332,5822,964
Expenses 1,5941,6621,6361,4821,8371,7811,6681,7781,8851,9161,8541,6632,035
Operating Profit 498598573526576763746342685693778919929
OPM % 24%26%26%26%24%30%31%16%27%27%30%36%31%
Other Income 878492109125139702206578-2710434
Interest 24447320016214914713812595
Depreciation 6977908791909111510599108109111
Profit before tax 514601571543603810525284496525505788757
Tax % 20%21%15%14%16%20%22%16%16%13%11%9%26%
Net Profit 409473487468506645412238415459449714558
EPS in Rs 10.2211.8012.1611.6812.6216.119.995.7710.0611.1210.8717.2913.52

Last Updated: September 29, 2026, 8:16 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 10:32 pm

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3,9183,8294,7945,5307,4868,1278,6299,50710,42110,787
Expenses 3,1413,1243,5504,1515,6446,4296,3587,0827,3337,468
Operating Profit 7787051,2441,3791,8421,6982,2722,4253,0883,319
OPM % 20%18%26%25%25%21%26%26%30%31%
Other Income 2096494148200163369555218189
Interest 1840118482817378562506
Depreciation 28386278123270335395429427
Profit before tax 9416911,2651,4401,8711,5632,2892,2082,3152,574
Tax % 26%26%24%25%26%20%18%19%12%
Net Profit 6945149581,0841,3891,2481,8761,7862,0382,180
EPS in Rs 17.3312.8323.9227.0734.6831.1646.8443.2949.3652.80
Dividend Payout % 0%0%32%0%0%0%0%0%2%

YoY Net Profit Growth

Year2018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-25.94%86.38%13.15%28.14%-10.15%50.32%-4.80%14.11%
Change in YoY Net Profit Growth (%)0.00%112.32%-73.23%14.98%-38.29%60.47%-55.12%18.91%

Mankind Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2018-2019 to 2025-2026.

Growth

Last Updated: September 5, 2025, 2:40 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 7, 2026, 4:30 am

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 404040404040404141
Reserves 2,9573,0253,6114,6946,5007,7449,66314,28116,356
Borrowings 36019031016885247,3835,571
Other Liabilities 6525968771,0451,7101,5831,7902,7522,658
Total Liabilities 4,0093,8514,5315,8808,9399,37111,51624,45824,625
Fixed Assets 5347789459872,9273,1423,5524,0763,926
CWIP 322211148166387495209207420
Investments 1,4021,6981,7842,3972,5263,1024,21516,68316,523
Other Assets 1,7511,1641,6552,3303,1002,6323,5403,4913,756
Total Assets 4,0093,8514,5315,8808,9399,37111,51624,45824,625
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 5405379601,0228211,7991,7362,3502,752
Cash from Investing Activity + -516-306-396-1,127-1,360-1,041-1,665-12,178-388
Cash from Financing Activity + 8-240-55989579-710-59,816-2,477
Net Cash Flow 31-95-16404866-11-113
Free Cash Flow 309371795830-1,3601,2191,4561,9962,317
CFO/OP 102%111%99%103%70%123%95%116%104%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow309.00371.00795.00830.00-1,360.001,219.001,456.001,996.002,317.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 2313322423223334
Inventory Days 120126124169183132160153
Days Payable 1151011131221331037579
Cash Conversion Cycle 273843727352118108
Working Capital Days 95444142264055-48
ROCE %22%36%33%30%21%24%15%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 76.50%76.50%74.88%74.87%74.87%72.71%72.70%72.67%72.67%72.66%72.66%72.63%
FIIs 4.18%6.74%9.87%11.58%12.37%13.34%12.92%13.07%12.83%11.34%10.24%9.45%
DIIs 4.56%9.78%11.14%9.94%9.91%11.05%11.47%11.50%11.91%13.26%14.46%15.39%
Public 14.76%6.97%4.10%3.61%2.86%2.89%2.89%2.75%2.57%2.75%2.63%2.53%
No. of Shareholders 1,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,5971,79,5491,70,3471,77,5391,77,6061,66,715
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Growth Mid Cap Fund 2,299,994 1.13 516.741,480,1002026-06-11 02:53:0555.39%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 2,248,970 7.58 505.282,312,8422026-06-11 02:53:05-2.76%
Nippon India Large Cap Fund 1,761,039 0.77 395.651,472,2802026-06-11 02:53:0519.61%
Aditya Birla Sun Life Flexi Cap Fund 1,664,835 1.46 374.041,365,5442026-06-11 02:53:0521.92%
Axis ELSS Tax Saver Fund 1,393,048 0.99 312.981,330,9112026-02-23 00:46:554.67%
Franklin India Opportunities Fund 1,231,676 3.24 276.72N/AN/AN/A
Nippon India Pharma Fund 1,131,195 3.04 254.15907,1542026-03-23 03:35:2224.7%
Axis Focused Fund 1,120,896 2.33 251.831,037,5962026-02-23 00:46:558.03%
Axis Flexi Cap Fund 1,076,417 1.93 241.84N/AN/AN/A
Franklin India Mid Cap Fund 1,029,108 1.91 231.21N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 49.2847.7532.0035.7831.59
Diluted EPS (Rs.) 49.2047.6832.0035.7831.59
Cash EPS (Rs.) 63.5058.0340.5240.0734.96
Book Value[Excl.RevalReserv]/Share (Rs.) 347.37239.04190.30157.68121.39
Book Value[Incl.RevalReserv]/Share (Rs.) 347.37239.04190.30157.68121.39
Revenue From Operations / Share (Rs.) 295.87257.99218.41194.25155.13
PBDIT / Share (Rs.) 86.1570.2950.6654.5545.41
PBIT / Share (Rs.) 71.1060.3542.5250.3942.44
PBT / Share (Rs.) 60.6959.5241.4148.9341.94
Net Profit / Share (Rs.) 48.4548.0932.3835.9131.99
NP After MI And SOA / Share (Rs.) 48.2547.7532.0035.7831.59
PBDIT Margin (%) 29.1127.2423.1928.0829.27
PBIT Margin (%) 24.0323.3919.4625.9427.35
PBT Margin (%) 20.5123.0618.9525.1827.03
Net Profit Margin (%) 16.3718.6414.8218.4820.61
NP After MI And SOA Margin (%) 16.3018.5014.6518.4220.36
Return on Networth / Equity (%) 13.8920.4317.2423.2826.79
Return on Capital Employeed (%) 13.2724.5621.6930.9433.87
Return On Assets (%) 7.1715.9813.1915.6719.85
Long Term Debt / Equity (X) 0.380.000.000.010.01
Total Debt / Equity (X) 0.590.020.020.140.05
Asset Turnover Ratio (%) 0.610.950.870.981.01
Current Ratio (X) 1.233.102.321.682.89
Quick Ratio (X) 0.862.371.521.012.01
Inventory Turnover Ratio (X) 6.691.210.500.640.57
Interest Coverage Ratio (X) 8.2883.9845.6337.2990.29
Interest Coverage Ratio (Post Tax) (X) 5.6458.4530.1725.5464.60
Enterprise Value (Cr.) 108143.4991239.850.000.000.00
EV / Net Operating Revenue (X) 8.868.830.000.000.00
EV / EBITDA (X) 30.4232.400.000.000.00
MarketCap / Net Operating Revenue (X) 8.198.900.000.000.00
Price / BV (X) 6.989.830.000.000.00
Price / Net Operating Revenue (X) 8.198.900.000.000.00
EarningsYield 0.010.020.000.000.00
Advertisements
Explore Industry-wise Company financial data